# E-cigarettes, Nicotine Inhaler, and Blood Vessel Function

> **NCT03072628** · NA · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 148 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **OTHER:** e-cig with nicotine
- **OTHER:** e-cig without nicotine
- **OTHER:** nicotine inhaler
- **OTHER:** sham control

## Key facts

- **NCT ID:** NCT03072628
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-11
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03072628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03072628, "E-cigarettes, Nicotine Inhaler, and Blood Vessel Function". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03072628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*